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The complexation of ZnII ions with quinolone in aqueous solution de-
pends mainly upon pH. To investigate the pH dependence of the
complexation between ZnII and the quinolone derivative ciprofloxacin
(abbreviation cfH), UV-Vis spectroscopy was used. The crystal
structure of the compound C17H19N3O3F2 · ZnCl4 · 2H2O (com-
pound I) was determined by X-ray diffraction, which showed the
structure to be ionic, consisting of a tetrachlorozincate(II) dianion
and two protonated, monocationic ciprofloxacin molecules. Com-
pound II (Zn(cf)2 · 3H2O) was obtained as microcrystals from an
aqueous solution of ciprofloxacin hydrochloride and zinc sulphate
adjusted to pH = 8 by the addition of sodium hydroxide. Both com-
plexes were characterized by elemental analysis, mass spectrome-
try, TG analysis and IR spectroscopy. From the analysis of these re-
sults we have proposed a probable mode of bonding for the
complexation of ZnII to ciprofloxacin in compound II.
Key words: fluoroquinolone, metal-ion complexation, ciprofloxacin,
zinc.
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INTRODUCTION
Ciprofloxacin (1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
3-quinoline carboxylic acid) is a synthetic fluoroquinolone antibacterial agent
with a broad spectrum of activity.1 It is active against a wide variety of aero-
bic gram-negative and gram-positive bacteria. The mechanism of ciprofloxa-
cin action involves inhibition of bacterial DNA gyrase, which is essential for
DNA replication, and it has been proposed that metal complex intermedi-
ates are involved in this process.2–3 In contrast, the application of quinolo-
nes in the presence of antacids or other drugs which contain metal ions, es-
pecially when administered simultaneously or within a short period of time,
reduced their bioavailability significantly.4–6 Polk et al. conducted a four-
way crossover study in 12 healthy men to investigate the effects of multivi-
tamins with zinc on the absorption of ciprofloxacin and found that »Multivi-
tamins Stress tabs 600« with zinc reduced bioavailability by an average of
24%.7 It has been proposed that this reduction in bioavailability is a conse-
quence of metal complex formation in the gastric system.4
The protonation constants of ciprofloxacin and the formation constants
of its complexes with copper(II) were determined by potentiometric titration.8–9
These studies proposed the presence of numerous species in solution, though
only one complex could be isolated as a solid.
Our aim was to use UV-Vis spectroscopy to determine the pH depend-
ence of the complexation of ZnII with ciprofloxacin in aqueous solution, and to
isolate and characterize the complexes formed.
EXPERIMENTAL
Synthesis
All chemicals and reagents were used as received from commercial sources. The
solutions were prepared with twice-distilled water.
cfH22 · ZnCl4 · 2H2O (Compound I)
Ciprofloxacin (0.270 g) was dissolved in 10 ml of 0.10 M HCl and 0.050 g of ZnCl2
was added. The solution was stirred and a white precipitate appeared after one day.
The precipitate was filtered and washed with ethanol. A saturated aqueous solution
of the compound was then prepared and kept in an ethanol chamber. After a few
weeks, transparent colourless needle shaped crystals appeared and were analyzed
by X-ray diffraction.
Anal. Calcd. for C34H42N6Cl4F2O8Zn (Mr = 907.98): C 44.97, H 4.67, N 9.26%;
found: C 44.83, H 4.31, N 9.18%.
The same product was obtained from a saturated aqueous solution of ciprofloxacin
hydrochloride at pH = 6 when ZnSO4 · 7H2O was added (mole ratio cfH : Zn = 2 : 1) .
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Zn(cf)2 · 3H2O (Compound II)
A saturated aqueous solution of ciprofloxacin hydrochloride, pH = 8, was prepa-
red (the pH was adjusted with 0.10 M NaOH). ZnSO4 · 7H2O was added and the pH
was adjusted back to pH = 8 (mole ratio cfH : Zn = 2 : 1). The solution was stirred for
one day, though a white precipitate appeared after just half an hour. The precipitate
was filtered, washed with ethanol and dried at 60 °C for 5 hours.
Anal. Calcd. for C34H40N6F2O9Zn (Mr = 780.17): C 52.34, H 5.18, N 10.78%;
found: C 52.76, H 5.34, N 10.77%.
The product was insoluble in water, ethanol, methanol, chloroform, acetone, ether,
ethylene glycol, 2-propanol, carbon tetrachloride, cyclohexanone, dichloromethane and
dimethyl sulfoxide. It decomposed in diluted solutions of all strong acids. All attempts
to prepare single crystals were unsuccessful.
Measurements
Spectrometric measurements were performed on a Perkin-Elmer UV-Vis-NIR
Lambda 19 instrument equipped with 10-mm quartz cuvettes. Aqueous solutions
of ciprofloxacin hydrochloride (1.0  10–4 mol L–1) and ciprofloxacin hydrochloride/
/zinc sulphate (1.0  10–4 mol L–1 ciprofloxacin, 1.0  10–2 mol L–1 zinc sulphate)
were prepared for all integer values of pH from 2–10. In each case the pH was
adjusted by the addition of either 0.10 mol L–1 NaOH or 0.10 mol L–1 HCl, as appro-
priate. UV-Vis spectra were recorded for all of these solutions in the range 220 to
400 nm.
The elemental analyses were carried out on a Heraeus CHNO Rapid Element
Analyser at the University of Hamburg.
Infrared spectra (IR) were recorded on a Perkin-Elmer 1720 IR Fourier Trans-
form Spectrophotometer in poly-(chlorotrifluoroethylene) oil mulls (4000–1300 cm–1)
and nujol (1300–400 cm–1) between CsI windows, resolution 2 cm–1, 10 scans.
Thermogravimetric (TG) data were recorded on a Mettler TA 3000 system with
platinum crucibles at a heating rate of 5 K min–1 and dry airflow rate of 20 mL
min–1. The samples weighed approximately 10 mg.
Mass spectrometry was performed on a VG-Analytical AutospecEQ instrument.
Ionization was accelerated with Cs+ ions with energies of 20–30 keV (Fast Atom
Bombardment, FAB); m-nitrobenzyl alcohol (NBA) was used as matrix.
Powder diffraction analyses were performed on a Guinier Camera 620 with a
Guinier Monochromator 615 using Cu-Ka radiation. Powder Diffraction File PDF-2
was used for data matching.10
Decomposition of complexes was performed in an autoclave, specially designed
by Viktor d.o.o., Radomlje at Ljubljana, at 150 °C for 5 h.
The pH's of the solutions were determined using a pH 540 GLP WTW (Wissen-
schaftlich-Technische Werkstätten) pH-meter equipped with a WTW SenTix pH elec-
trode.
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RESULTS AND DISCUSSION
UV Spectroscopy
UV-Vis spectroscopy was used to investigate the pH dependence of the
complexation of ZnII with ciprofloxacin in aqueous solution.
The absorption maxima for an aqueous solution of ciprofloxacin hydro-
chloride, at pH = 2, appeared at 277, 316 and 328 nm. On increasing the pH,
the maximum at 277 nm shifted to lower values and the maxima at 316 and
328 nm shifted to higher values. These changes can be attributed to the ex-
tent of ionization of the carboxylic group as a consequence of the removal of
a proton.11 At pH = 7, the absorption maxima appeared at 272, 322 and 333
nm.
These spectra were compared with those of a solution of zinc sulphate
and ciprofloxacin hydrochloride at the same pH values. At pH = 2–6, no sig-
nificant differences were observed between the spectra of the two solutions,
indicating no interaction between the ZnII ions and the ciprofloxacin. At
pH  7 (Figure 1), both bathochromic and hypsochromic shifts were found in
the spectra with the bands of ciprofloxacin at 322 and 333 nm shifted to 318
and 330 nm, respectively, in the presence of ZnII ions, and the band at 272
nm shifted to 275 nm. Thus we propose that, at pH  7, there is complexa-
tion between ZnII ions and ciprofloxacin. On reaching pH = 9, a copious
quantity of a white precipitate was seen to form. This precipitate was fil-
tered off and analyzed using X-ray powder diffraction. Data matching with
Powder Diffraction File PDF-2 confirmed the precipitate to be Zn5(OH)8Cl2 ·
H2O.
10
Transport of quinolone across the bacterial cytoplasmic membrane is
strongly pH dependent, peaking at neutral pH.12 Y. Kawai et al.13 have pro-
posed that zwitterionic and uncharged quinolone species are responsible for
diffusion through cytoplasmic membranes. In the stomach the pH range is
between 2–5, whilst in the intestines the pH varies from 6–8. The results of
our UV-Vis spectroscopic studies show that quinolones interact extensively
with ZnII ions only at pH = 7 and higher. Thus, in the stomach, where there
is no metal-quinolone complexation due to acidic pH's, the absorption of qui-
nolone is very low. Intensive transport of quinolone across the bacterial cyto-
plasmic membrane probably occurs extensively in the intestines, where the
pH is high enough. Additionally, the metal-quinolone complexation probably
occurs initially in the intestines. H. H. M. Ma et al.14 have investigated the
mechanism of the reduction in antimicrobial activity of ciprofloxacin caused
by metal cations. They have reported that the presence of metal ions results
in a higher ciprofloxacin uptake by bacterial cells compared to that of the
drug alone. The reason for the reduced bioavailability of the drug is the loss
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of ciprofloxacin activity that occurs when the cation chelates the carbonyl
and the carboxylate functional groups of the molecule. The exact mecha-
nisms of these processes have not yet been fully elucidated.
Determination of the Presence of Cl– and SO4
2– Ions in the Samples
Decomposition of complexes was performed in concentrated HNO3 in an
autoclave. After decomposition, the samples were diluted with water to 100
mL, and the qualitative presence of Cl– and SO4
2– ions in the samples was
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Figure 1. UV-Vis spectra of the solutions of (a) ciprofloxacin and (b) ciprofloxacin and
zinc sulphate at pH = 8.
determined by means of AgNO3 and BaCl2 respectively. The decomposition
product of compound I was found to contain Cl– ions, and their concentra-
tion was determined with an ion selective electrode.
Anal. Calcd. for C34H42N6Cl4F2O8Zn: 15.6%; found: 15.2%.




The IR spectra of quinolones are most indicative in the region 1800–
1300 cm–1. The IR spectra of ciprofloxacin, ciprofloxacin hydrochloride hy-
drate and ciprofloxacin hexahydrate have been assigned.15–16 The character-
istic band for the (C=O) vibration of the carboxylic group in ciprofloxacin
hydrochloride hydrate is at 1707 cm–1.15 In the IR spectra of ciprofloxacin
and ciprofloxacin hexahydrate, there are no analogous peaks due to the de-
protonation of COOH group.16 Some authors have pointed out that ionic car-
boxylates show no carbonyl band around 1700 cm–1, but instead have two
absorption bands due to the asymmetric (nas(O–C–O)) and symmetric
(ns(O–C–O)) stretching vibrations that occur in the ranges 1610–1550 cm
–1
and 1400–1280 cm–1, respectively.17 It is difficult, however, to assign unam-
biguously these vibrations in the spectra of quinolones on account of the nu-
merous other bands present in these regions, so only the region from 1800–
1500 cm–1 is reported here. The band at 1618 cm–1 in the IR spectrum of
ciprofloxacin (Figure 2, spectrum a) was ascribed to the stretching vibration
of the pyridone (C=O) group.
As can be seen from the IR spectrum of compound I (Figure 2, spectrum
b), both of the n(C=O) absorption bands are shifted to slightly higher wave-
numbers (1718 cm–1 and 1629 cm–1). Similar shifts were observed in the IR
spectra of the norfloxacin complex (nf H 2)(nf H ) ZnCl4 Cl · 2H2O.
18
The IR spectrum of compound II (Figure 2, spectrum c) shows no band for
the n(C=O) vibration of the carboxylic group in the region 1800–1500 cm–1,
indicating that the –COOH group has been deprotonated. The spectrum is
generally very similar to that of the copper complex Cu(cfH)2 Cl2 · 6H2O,
where the copper ion is coordinated with the pyridone oxygen atom and one
of the carboxylic oxygens of the quinolone molecule.19
Thermogravimetric Analysis
The product of the thermal decomposition of both complexes is ZnO (as
confirmed by X-ray powder diffraction). The weight loss of compound I from
25 °C to 90 °C corresponds to dehydration. The experimental value (4.40%)
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is in fair agreement with the calculated value for the loss of two water mole-
cules per molecule of substance (3.97%). The reason for the slight discrep-
ancy is probably the hygroscopicity of the complex, a difficulty that has been
reported for other metal-quinolone complexes.20 The shape of the DTG curve
of the dehydration reaction shows the presence of moisture. The pyrolysis of
compound I begins at 220 °C and ends at 645 °C. From the mass of the resi-
due of the thermal decomposition it was calculated that the sample contains
4.88% of zinc (cf. calculated value of 7.20%). However, it is known that zinc
oxide sublimes at elevated temperatures.21 After the decomposition of the
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Figure 2. IR spectra of (a) ciprofloxacin, (b) cfH2 2 ZnCl4 · 2H2O and (c) Zn(cf)2 ·
3H2O.
compound in the autoclave, zinc concentration was determined by titration
with EDTA. The solution was found to contain 6.97% of zinc, suggesting
that the earlier zinc assay (determined by TGA) was low due to sublimation
during the thermal decomposition.
Dehydration of compound II ends at 110 °C and the weight loss corre-
sponds to 7.12% water (calculated value for three water molecules is 6.93%).
The DTG curve of the dehydration process is not split, suggesting that all
water molecules are equally strongly held within the solid, in contrast to the
related magnesium complex with ciprofloxacin.22 The pyrolysis begins at 234 °C
and ends at 593 °C with a total weight loss of 92.4%, corresponding to 5.13%
of zinc (cf. a calculated value of 8.38%). The reason for this discrepancy is
probably the sublimation of zinc oxide again.
Mass Spectrometry
In the mass spectra of compounds I and II, intense mass peaks at m/z
332 and 663 were observed. The first mass peak corresponds to the cfH2
+
ion and the second one to the (cfH)(cfH2)
+ ion. Intense peaks at m/z 725,
727 and 729 were observed in the mass spectra of compound II, correspond-
ing to the Zn(cf)(cfH2)
+ ion considering all three isotopes of zinc. No such
peaks appeared in the mass spectrum of compound I. These results are
again consistent with the presence of direct metal-ligand bonding in com-
pound II.
Thus, on the basis of all these results, we propose that in compound II the
zinc binds to the quinolone ligand in the fashion depicted in the Scheme 1.
X-ray Structure Analysis of Compound I
Crystal Structure Determination
Crystal data for I. – C17H19N3O3F2 · ZnCl4 · 2H2O, M = 907.9, triclinic,
space group P1(no. 2), a = 9.872(1), b = 13.863(1), c = 16.593(1) Å, a = 70.40(1),
b = 76.78(1), g = 69.50(1)°, V = 1987.9(3) Å3, Z = 2, Dc = 1.517 g cm
–3, m(Cu-
-Ka) = 39.0 cm–1, F(000) = 936, T = 293 K; clear platy needles, 0.73  0.23 
0.10 mm, Siemens P4/PC diffractometer, w-scans, 5554 independent reflec-
tions. The structure was solved by direct methods and the non-hydrogen at-
oms were refined anisotropically using full matrix least-squares based on F2
to give R1 = 0.068, wR2 = 0.178 for 4246 independent observed absorption
corrected (y-scans) reflections Fo > 4(Fo), 2Q  120° and 505 parameters.
The N–H and O–H hydrogen atoms were located from DF maps and refined
isotropically subject to an X–H distance constraint (0.90 Å). Refinements were
carried out using the SHELXTL program system.23
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Description of the Structure
The X-ray analysis of the salt formed between ciprofloxacin and ZnCl2 in
hydrochloric acid showed the crystals to contain two crystallographically in-
dependent ciprofloxacinium cations A and B (Figure 3 depicts molecule A), a
single tetrachlorozincate(II) dianion and two water molecules. The two inde-
pendent ciprofloxacinium cations have very similar conformations, the only
major difference being in the relative orientations of the piperazinium rings
(the torsional twists about the C(7)–N(21) bond differ by ca. 110°). In both
molecules, protonation is on the terminal nitrogen atom N(24) of the pipe-
razine ring and not at the substituted N(21) position. In each case there is
an intramolecular O–H···O hydrogen bond between the terminal carboxylic
oxygen O(11) and the quinolone carbonyl oxygen O(1) (the O···O, H···O dis-
tances / Å and the O–H···O angles / ° are 2.55, 1.70, 156 for molecule A and
2.52, 1.76, 139 for molecule B). In both molecules, the carbonyl character of
the quinolone C(4)–O(1) bond is retained (1.251(7) and 1.258(6) Å in mole-
cules A and B, respectively, Table I). There is, however, a distinct pattern of
delocalization within this ring, a pattern of bonding directly analogous to that
observed in the copper and zinc salts of the related norfloxacin.18
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Figure 3. The p-p stacking of one of the two crystallographically independent cipro-
floxacinium cations (type A) present in the crystals of I. The O–H···O hydrogen bond-
ing geometry is (O···O and H···O distances / Å, O–H···O angles / °): a) 2.55, 1.70, 156.
TABLE I
Bond lengths / Å for the two independent ciprofloxacin molecules A and B
present in the structure of I
A B A B
N(1)–C(2) 1.338(8) 1.336(7) N(1)–C(9) 1.418(7) 1.402(6)
N(1)–C(11) 1.456(8) 1.461(7) F(1)–C(6) 1.358(6) 1.363(6)
O(1)–C(4) 1.251(7) 1.258(6) C(1)–O(12) 1.207(9) 1.204(7)
C(1)–O(11) 1.318(10) 1.333(7) C(1)–C(3) 1.500(9) 1.481(8)
C(2)–C(3) 1.354(9) 1.378(8) C(3)–C(4) 1.432(8) 1.428(7)
C(4)–C(10) 1.439(8) 1.441(8) C(5)–C(6) 1.344(8) 1.358(8)
C(5)–C(10) 1.414(7) 1.400(7) C(6)–C(7) 1.413(8) 1.413(8)
C(7)–C(8) 1.384(7) 1.378(8) C(7)–N(21) 1.395(7) 1.388(7)
C(8)–C(9) 1.392(8) 1.400(8) C(9)–C(10) 1.393(8) 1.406(7)
C(11)–C(12) 1.473(9) 1.493(9) C(11)–C(13) 1.487(8) 1.478(8)
C(12)–C(13) 1.487(10) 1.496(10) N(21)–C(26) 1.455(7) 1.462(7)
N(21)–C(22) 1.475(7) 1.474(8) C(22)–C(23) 1.489(8) 1.495(9)
C(23)–N(24) 1.497(8) 1.489(9) N(24)–C(25) 1.487(8) 1.477(10)
C(25)–C(26) 1.512(8) 1.503(9)
The two independent molecules A and B each stack with their centro-
symmetrically related counterparts. In molecules of type A the ring systems
are offset, the centres of the two quinolone rings being separated by 3.92 Å
whilst the mean interplanar separation is 3.48 Å (Figure 3). The mode of
stacking of molecules of type B is similar (Figure 4) but with a greater over-
lap of the two quinolone rings (centroid···centroid separation: 3.49 Å, mean
interplanar separation: 3.47 Å). The p-p stacking interaction between mole-
cules of type B is supplemented by N–H···O and O–H···O hydrogen bonding
to, and including, the solvent water molecules to produce an H-bonded ma-
crocyclic dimer. Type A and type B molecules are also p-stacked, the planes
of the ring systems being inclined by only 3° and separated by ca. 3.4 Å (Fig-
ure 5). There are secondary weak N–H···Cl and O–H···Cl interactions to-
gether with stronger O–H···O hydrogen bonds linking these two types of mo-
lecule. The total assembly of type A and type B molecules is thus a continu-
ous p-stack in the sequence …AABBAA… with adjacent stacks being cross-
-linked by a combination of N–H···Cl and O–H···Cl hydrogen bonding inter-
actions (Figure 6). This mode of packing is very similar to that observed in
the solid state for the copper and zinc norfloxacin species.18
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Figure 4. The p-p stacking of type B molecules showing also the supplementary link-
ing by N–H···O and O–H···O hydrogen bonding involving hydrate molecules. The
N–H···O and O–H···O hydrogen bonding geometries are (X···O and H···O distan-
ces / Å, and X–H···O angles / °): b) 2.52, 1.76, 139; c) 2.93, 2.15, 144; d) 2.74, 1.85,
168; e) 2.74, 1.94, 147.
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Figure 6. The cross-linked continuous …AABBAA… p-p stacks present in the crys-
tals of compound I.
Figure 5.The - stacking between a molecule of type A and a molecule of type B,
showing also the weak N–H···Cl and O–H···Cl interactions and the strong O–H···O
hydrogen bonding. The N–H···Cl, O–H···Cl and O–H···O hydrogen bonding geome-
tries are (X···O and H···O distances / Å and X–H···O angles / °): a) 2.55, 1.70, 156; b)
2.52, 1.76, 139; c) 2.93, 2.15, 144; e) 2.74, 1.94, 147; f) 3.32, 2.42, 177; g) 3.25, 2.52,
138. The Zn–Cl distances are in the range 2.231(2)–2.274(2) Å.
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SA@ETAK
Sinteza i karakterizacija dvaju novih kompleksa cinka(II)
s ciprofloksacinom. Kristalna struktura [C17H19N3O3F]2 · [ZnCl4] · 2H2O
Marija Zupan~i~, Iztok Turel, Peter Bukovec, Andrew J. P. White
i David J. Williams
Nastajanje kompleksa iona ZnII s kinolonom, u vodenoj otopini, ovisi uglavnom o
pH. Da bi se prou~avala pH-ovisnost kompleksiranja ZnII i kinolonskog derivata
ciprofloksacina (skra}eno cfH) primjenjena je UV-Vis spektroskopija. Difrakcijom
X-zraka odre|ena je kristalna struktura [C17H19N3O3F]2 · [ZnCl4] ·2H2O (spoj I)
koja je pokazala da je spoj ionski i sastoji se od dianinona tetraklorocinkata(II) i
dvije protonirane, monokationske molekule ciprofloksacina. Spoj II ([Zn(cf)2] · 3H2O)
dobiven je u obliku mikrokristala iz vodene otopine ciprofloksacin-hidroklorida i cin-
kova sulfata pode{ene na pH = 8 dodavanjem natrijeva hidroksida. Oba kompleksa
okarakterizirana su elementnom analizom, masenom spektroskopijom, TG analizom
i IR spektroskopijom. Nakon analize tih rezultata, predlo`en je vjerojatni na~in ve-
zanja ZnII na ciprofloksacin u spoju II.
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